Enzymatica

Rwanda
Byumba, Northern Province, Rwanda, 223 70

Company profile

Enzymatica company profile

Enzymatica is a life science company whose business concept is to offer effective help against some of our most common diseases where viruses or bacteria play a decisive role. Over a short period the company has developed a unique oral spray for colds, ColdZyme®, and launched it on six markets. Since launch the product has become one of the leading articles for colds in Swedish pharmacies. Development includes medical devices in upper respiratory infections and oral health, and veterinary products. The company is headquartered in Lund, Sweden and is listed on Nasdaq First North.

Business identity

Contact email
[email protected]
Phone number
+46 20 14 20 15
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2007-01-01, Year

Headquarters

Postal code
223 70
Country code
RW
Continent
Africa

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
3
Total equity funding
$15.4M
Last funding
Post IPO Equity / $12.8M / 2024-09-12
Last equity funding
Post IPO Equity / $12.8M
Investors
3
Articles
64
Exited on
2015-06-15

Founders and investors

Investors

Björn AlgkvistHåkan RoosMATS ANDERSSON